GGrantIndex
← Leaderboards

Ellen M Gravallese

Beth Israel Deaconess Medical Center

$8,261,641
Attributed
$10,769,422
Total exposure
7
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.1M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$10,769,422 · 7

By mechanism

R01$7,433,273 · 4
T32$2,525,449 · 1
R21$810,700 · 2

Top collaborators

Most similar at Beth Israel Deaconess Medical Center

Same institution · by research overlap

Others in their field

Top investigators on “Osteoclasts

Research focus

OsteoclastsBone LossCellsLinkPathway InteractionsBoneCytokineGrantIn VivoOsteoblastsSourceProductionInflammatoryArthritisMediatingBone ResorptionOsteopeniaRheumatoid ArthritisOsteoblast DifferentiationProteinsSignal TransductionOsteogenesisBone MarrowPrevent

Grant awards (29)

Immunologic Mechanisms and Rheumatic Diseases$548,620
T32 · FY2025 · AR · contact PI
Novel approaches to promote healing of bone loss in inflammatory arthritis$511,095
R01 · FY2025 · AR
Novel approaches to promote healing of bone loss in inflammatory arthritis$509,531
R01 · FY2024 · AR
Immunologic Mechanisms and Rheumatic Diseases$502,960
T32 · FY2024 · AR
Novel approaches to promote healing of bone loss in inflammatory arthritis$524,436
R01 · FY2023 · AR
Immunologic Mechanisms and Rheumatic Diseases$492,856
T32 · FY2023 · AR
Novel approaches to promote healing of bone loss in inflammatory arthritis$539,701
R01 · FY2022 · AR
Immunologic Mechanisms and Rheumatic Diseases$503,091
T32 · FY2022 · AR
Immunologic Mechanisms and Rheumatic Diseases$477,922
T32 · FY2021 · AR
The STING pathway and cytosolic nucleic acid sensors in bone homeostasis$357,867
R01 · FY2021 · AR · contact PI
The STING pathway and cytosolic nucleic acid sensors in bone homeostasis$376,473
R01 · FY2020 · AR · contact PI
The STING pathway and cytosolic nucleic acid sensors in bone homeostasis$219,100
R01 · FY2019 · AR · contact PI
The STING pathway and cytosolic nucleic acid sensors in bone homeostasis$159,580
R01 · FY2019 · AR · contact PI
The STING pathway and cytosolic nucleic acid sensors in bone homeostasis$368,500
R01 · FY2018 · AR · contact PI
Novel approaches to the treatment of bone loss in rheumatoid arthritis$184,250
R21 · FY2018 · AR · contact PI
The STING pathway and cytosolic nucleic acid sensors in bone homeostasis$368,500
R01 · FY2017 · AR · contact PI
Novel approaches to the treatment of bone loss in rheumatoid arthritis$221,100
R21 · FY2017 · AR · contact PI
Regulatory role for cytosolic nucleic acid sensors in bone$184,250
R21 · FY2015 · AR · contact PI
Regulatory role for cytosolic nucleic acid sensors in bone$221,100
R21 · FY2014 · AR · contact PI
Inhibition of osteoblast function in bone erosion in rheumatoid arthritis$300,760
R01 · FY2013 · AR · contact PI
Inhibition of osteoblast function in bone erosion in rheumatoid arthritis$351,767
R01 · FY2012 · AR · contact PI
Inhibition of osteoblast function in bone erosion in rheumatoid arthritis$351,767
R01 · FY2011 · AR · contact PI
Inhibition of osteoblast function in bone erosion in rheumatoid arthritis$366,424
R01 · FY2010 · AR · contact PI
Inhibition of osteoblast function in bone erosion in rheumatoid arthritis$370,125
R01 · FY2009 · AR · contact PI
PATHOGENESIS OF BONE EROSION IN RHEUMATOID ARTHRITIS$310,279
R01 · FY2007 · AR · contact PI
PATHOGENESIS OF BONE EROSION IN RHEUMATOID ARTHRITIS$334,293
R01 · FY2006 · AR · contact PI
PATHOGENESIS OF BONE EROSION IN RHEUMATOID ARTHRITIS$371,025
R01 · FY2005 · AR
PATHOGENESIS OF BONE EROSION IN RHEUMATOID ARTHRITIS$371,025
R01 · FY2004 · AR
PATHOGENESIS OF BONE EROSION IN RHEUMATOID ARTHRITIS$371,025
R01 · FY2003 · AR